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Abstract 
Purpose: To investigate the effect of Achyranthes bidentata Blume. Extract (ABBE) on carrageenan-
induced chronic prostatitis in rats. 
Methods: Experimental chronic non-bacterial prostatitis (CNP) was induced in rats by 1 % carrageenan 
(0.1 mL). Prostate index (PI) and prostate specific antigen (PSA) were determined after 3 weeks of 
adiministration. Relative inflammatory factors, viz, tumor necrosis factor-α (TNF-α), interleukin1β (IL-1β), 
cyclooxygenase-2 (COX-2), prostaglandin E2 (PEG2), transforming growth factor-β1 (TGF-β1) and 
connective tissue growth factor (CTGF) in the prostate tissues of all group rats were measured.  
Results: In CNP model, ABBE decreased PI and PSA compared with untreated control group (p < 
0.01). Morphometric analysis showed a significant reduction in chronic inflammatory cell infiltrates and 
interstitial fibrosis compared to control group. Reduced values of TNF-α, IL-1β, COX-2, PEG2 were 
observed in ABBE-treated groups compared with model group respectively (p < 0.01). Moreover, the 
levels of TGF-β1 and CTGF in ABBE-treated groups were significantly lower, and in addition, there was 
alleviation of the inflammatory state of the prostate gland (p < 0.01). 
Conclusion: ABBE showed antichronic non-bacterial prostatitis effect by multiple ways in rats, thus 
indicating its potential suitability for the treatment of chronic prostatitis. 
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Epidemiological research indicates prostatitis is 
one of the major medical healthcare problems in 
urology [1]. Prostatitis has been classified into 
three clinical entities: (I) acute bacterial prostatitis 
(II) chronic bacterial prostatitis; (III) chronic 
prostatitis (CP)/chronic pelvic pain syndrome 
(CPPS) [2]. Category III is further subdivided into 
category IIIA or inflammatory, and category IIIB 
or non-inflammatory. Chronic non-bacterial 
prostatitis (CNP), which belongs to category IIIA, 
is the most common form of the prostatitis 
syndromes, approximately eight times more 
prevalent than bacterial prostatitis [3]. CNP is 
characterized by chronic, idiopathic pelviperineal 
pain and an inflammatory subtype with 
leukocytes expressed in their prostatic secretions 
[4]. 
 
The plant, Achyranthes bidentata Blume., widely 
distributed in southwest of China, was the main 
material of traditional Chinese medicine ‘‘niuxi’’, 
was used as folk medicine for immune-
modulation [5], anti-tumor [6] and anti-bacterial 
[7,8], etc. In this study, we evaluated the effect of 
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ABBE against carrageenan-induced chronic non-






Achyranthes bidentata Blume was collected from 
Bozhou City, Anhui Province in China in May 
2015. Taxonomic identification of the plant was 
performed by Professor Hui Wang of Fudan 
University, in China. A voucher specimen (no. 
ABBE 20150504) was deposited in the 
herbarium of College of Pharmacy, Fudan 
University, China for future reference. The 
aqueous extract of ABBE was obtained by 
steeping three batches of dried Achyranthes 
bidentata Blume in water at 60 oC three times, 
each for one hour, and then drying the extract in 
an oven and thereafter freeze-drying it. One 
gram powder was equivalent to about 1.5 g 




Eight-week old male Wistar rats (300 – 350 g) 
were provided by the Experimental Animal 
Center of Shanghai Municipality (certificate no. 
SYXK 2008-0006). The animals had free access 
to food and water, and were allowed to 
acclimatize for at least one week before use. The 
rat experiment was approved by the Animal Care 
and Use Committee of Huadong hospital 
affiliated to Fudan University (approval ref no. 
20111013) and was carried out in compliance 
with Directive 2010/63/EU on the handling of 
animals used for scientific purposes [9]. 
 
Animal groups  
 
The rats were randomly divided into 6 groups of 
ten rats each: normal group, negative control 
group, positive control group (cernilton 100 
mg/kg) as well as ABBE groups, namely, 100, 
200 and 400 mg/kg doses. Treatments were 
given orally once daily for 3 weeks, dissolved in 
water. The drugs were given into the rats by 
intragastric administration. 
 
Preparation of carrageenan-induced chronic 
non-bacterial prostatitis (CNP) model 
 
CNP model rats were prepared as previously 
described [10]. Briefly, for sham group, prostates 
of each rat were injected with 0.1 mL saline, and 
the same volume of 1 % carrageenan in model 
and drug administration groups. Seven days 
later, rats in drug administration and positive 
groups were kept for oral administration of ABBE 
extract or cernilton for 3 weeks, the sham and 
model groups were given saline at the same 
time. 
 
Measurement of prostatic index (PI) and 
prostate specific antigen (PSA)  
 
The prostatic index (PI) of all rats was measured. 
PI = prostate weight (mg) / body weight (g). The 
blood sample of rats was get by eyeball removal 
after the prostates were revoming. The collected 
serum was separated at 3500 r/min for 15 min 
and used for determination of prostate specific 
antigen (PSA) by ELISA kits (Shenzhen Xin-Bo-
Sheng Biological Technology Co Ltd, China). 
 
Measurement of tumor necrosis factor-α 
(TNF-α) and interleukin 1β (IL-1β) 
 
Quantitative measurement of pro-inflammatory 
cytokines TNF-α and IL-1β was done in the 
prostate tissue of both CNP and treated groups 
using commercial ELISA assay kits (Shenzhen 
Xin-Bo-Sheng Biological Technology Co Ltd, 
China), according to manufacturer’s instruction. 
The samples and standards were all run in 
quadruplicate and the data are averaged. The 
results are expressed as pg/mL. 
 
Measurement of PGE2, COX-2, TGF-β1 and 
CTGF 
 
The effect of CNP on productions of PGE2, COX-
2, TGF-β1 and CTGF were measured in prostate 
tissues using commercial ELISA kits (Shenzhen 
Xin-Bo-Sheng Biological Technology Co Ltd, 
China). All assays were performed in 10 % 
prostate supernatant in accordance with 
manufacturer’s instructions. The amounts of 
PGE2, COX-2, TGF-β1 and CTGF in prostate 




The data are presented as mean ± standard 
deviation (SD), and were analyzed by one-way 
ANOVA followed by Tukey’s multiple comparison 
using SPSS 16.0 software for Windows. 
Differences were considered statistically 




Effect of ABBE on PI and PSA 
 
After 3 weeks of administration, the effects of 
oral administration of ABBE on the levels of PI 
and PSA are summarized in Table 1. In the 
model group, the levels of PI and PSA increased 
to 2.1 mg/g and 312.5 pg/mL, respectively (p < 
0.01). By contrast, after treatment with ABBE, 
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especially 400 mg/kg, the levels of PI and PSA 
had dropped significantly (p < 0.01). 
 
Table 1: Effect of ABBE on PI and PSA levels (mean 
± SD, n = 10) 
 
Group Dose (mg/kg) PI (mg/g） PSA(pg/mL) 
Normal — 0.8±0.2** 123.2±10.8** 
Negative 
contro — 2.1±0.2 312.5±20.5 
Cernilton 100 1.5±0.4 182.7±16.4** 
PSA-L 100 1.6±0.3 274.6±33.5 
PSA-M 200 1.3±0.2* 180.5±21.9* 
PSA-H 400 1.0±0.1** 154.2±14.3** 
*p < 0.05，**p < 0.01 vs. model group 
 
Effect of ABBE on TNF-α and IL-1β 
 
The TNF-α level of the sham group rats was 
100.8 pg/ml. Carrageenan-treatment caused 
significant increase in the level of TNF-α 
compared with the sham group (p < 0.01). Oral 
treatment of ABBE extract at doses of 400 mg/kg 
resulted in decrease of TNF-α level when 
compared to model group (p < 0.01). The level of 
IL-1β was significantly increased in model group 
compared to control group (p < 0.01). However, 
the IL-1β level was significantly decreased to 1, 
17.5 or 97.6 pg/mL at the dose of 200 and 400 
mg/kg groups respectively (p < 0.01, Table 2). 
 
Table 2: Effect of ABBE on TNF-α and IL-1β levels 
(mean ± SD, n = 10) 
 





Normal — 100.8±9.7** 73.6±6.4** 
Negative 
control — 165.4±14.2 176.1±12.1 
Cernilton 100 121.5±8.4** 114.5±11.7** 
PSA-L 100 148.3±16.8 152.7±15.8 
PSA-M 200 134.7±10.2* 117.5±10.7** 
PSA-H 400 116.5±9.3** 97.6±11.3** 
*p< 0.05，**p < 0.01 vs. model group 
 
Effect of ABBE on PGE2, COX-2, TGF-β1 and 
CTGF 
 
ABBE were assessed for their inhibitory activity 
on TGF-β1 and CTGF production. As shown in 
Table 3, the level of TGF-β1 was 72.6 pg/ml in 
sham group. Carrageenan caused significant 
increase in the level of TGF-β1 in model group (< 
0.01). After three weeks treatment of ABBE, the 
TGF-β1 level was dose-dependently decreased 
(p < 0.01). Similarly, the level of CTGF was 
notably elevated in model group when compared 
with the sham group (p < 0.01). However, in 
ABBE extract treated group, the elevation was 
suppressed compared with the model group (p < 
0.01). Carrageenan treatment stimulated the 
level of COX-2 compared to sham group (p < 
0.01). However, treatment of ABBE extract 
decreased the level of COX-2 (p < 0.01). The 
level of PEG2 was increased in model group 
compared to sham group (p < 0.01). Oral 
treatment of ABBE extract at 200 and 400 mg/kg 
resulted in significant decrease of PEG2 content 




Achyranthes bidentata Blume. is traditionally 
used in Chinese medicine for treatment of 
prostatitis in China. In our study, the 
experimental chronic non-bacterial prostatitis 
was induced by carrageenan. The PI and PSA 
levels of model group rats were increased proved 
that prostatitis was established successfully by 
carrageenan. Then the potential therapeutic 
effect of ABBE in rats with carrageenan-induced 
prostatitis was evaluated. The whole results 
showed that ABBE reduced COX-2 and PEG2 in 
model group rats. The TGF-β1 and CTGF levels 
of ABBE group rats were significantly decreased 
while the inflammatory state of the prostate gland 
were alleviated. Thus, the administration of 
ABBE for 3 weeks significantly inhibited the 
development of chronic inflammation and fibrosis 
in prostatic tissue. 
 
It is well accepted that the progression of CNP 
related to the complex network of cytokines, such 
as IL-1β and TNF-α [11,12]. IL-1β is a pro- 
inflammatory cytokine that induces the 
production of other inflammatory mediators 
involved with cellular recruitment, fever, acute 
 
     Table 3: Effect of ABBE on PGE2, COX-2, TGF-β1 and CTGF levels (mean ± SD, n = 10) 
 










** 12.5±1.2** 72.6±4.1** 56.7±3.4** 
-ve control   128.6±6.7 31.5±3.4 149.2±12.7 121.4±5.8 Cernilton 100 87.4±5.9** 16.2±2.8* 108.4±8.6* 87.4±6.1** 
PSA-L 100 105.6±4.8* 25.6±4.3 125.3±9.6* 114.4±7.1 
PSA-M 200 92.3±6.4** 16.4±3.2** 110.5±7.6** 92.4±8.4** 
PSA-H 400 79.2±4.5** 13.3±2.5** 86.7±8.1** 71.2±5.3** 
      -ve, negative; *P < 0.05，**p < 0.01 vs. model group 
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phase protein release, increase of vascular 
permeability, and hyperalgesia [13]. TNF-α, a 
pleiotropic pro-inflammatory cytokine, is rapidly 
produced by macrophages in response to tissue 
damage [14].  
 
Previous studies have shown that activation of 
transcription factor NF-κB by TNF-α is one of the 
myriad actions of TNF-α that cause genes to 
generate potentially cell - damaging oxidative 
enzymes, as well as further release of TNF-α, IL-
1β and other pro-inflammatory cytokines [15]. 
Cytokine - based therapies have been found to 
be useful in preventing progression of chronic 
prostatitis [16]. In the present study, the levels of 
TNF-α and IL-1β were increased in model group 
rats, whereas on treatment with ABBE extract at 
200 or 400 mg/kg, there were significant 
decreases in the cytokine levels. ABBE could 
suppress the release of pro-inflammatory 
mediators, which possess its anti-inflammatory 
activities. In this study, the COX-2 and PEG2 
levels of rats were examined. It was found that in 
model group, the levels of those factors were 
enhanced. However, the increased levels of 
COX-2 and PEG2 were reversed in treatment 
group of ABBE extract. In addition, it was found 
that ABBE extract at the dose of 400 mg/kg 
significantly decreased COX-2 and PEG2 levels. 
Therefore, the anti-CNP effect of ABBE extract 
may be related to its anti-inflammatory 
properties. 
 
TGF-β is the most extensively studied molecule 
in fibrosis and stimulates the production of 
reactive oxygen species (ROS) in various types 
of cells, whereas ROS activate TGF-β and 
mediate many of the fibrogenic effects of TGF-β 
[17]. TGF-β1 is known to induce fibroblast 
differentiation of into myofibroblast/smooth 
muscle cell in the human prostate [18]. In 
addition, other evidence suggests that pro-fibrotic 
effects of TGF-β may be partly mediated by 
CTGF [19]. As another potent profibrotic factor, 
CTGF is implicated in fibroblast proliferation, 
cellular adhesion, angiogenesis, and extracellular 
matrix (ECM) synthesis [20]. Previous studies 
showed that CTGF promotes inflammatory 
response [21]. Chronic inflammatory response 
can result in pathological wound repair and the 
accumulation of permanent fibrotic scar tissue at 
the site of injury and this fibrosis may lead to a 
decrease in organ function and, in some cases, 
organ failure and death [22]. Summarily, another 
possible hypothesis could be given that the TGF-
β1/CTGF pathway may also be involved in the 
CNP. The results indicate that ABBE could 
suppress the enhancement of the TGF-β1 
expression compared with model group rats. And 
400 mg/kg of ABBE could decrease the TGF-β1 
level of model rats significantly, as well as CTGF 
level. ABBE regulated the CTGF signaling 
pathway following the TGF-β1 stimulation. Thus, 
the anti-CNP effects of ABBE were also 




The results of this study demonstrate that ABBE 
has a significant anti- inflammatory effect on 
chronic prostatitis in rats, and may thus be 
suitable for the treatment of chronic prostatitis. 
There is, however, a need for further 
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